MTR anticorps (C-Term)
Aperçu rapide pour MTR anticorps (C-Term) (ABIN633804)
Antigène
Voir toutes MTR AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- C-Term
-
Specificité
- MTR antibody was raised against the C terminal of MTR
-
Réactivité croisée
- Humain
-
Purification
- Affinity purified
-
Immunogène
- MTR antibody was raised using the C terminal of MTR corresponding to a region with amino acids GSEQLDVADLRRLRYKGIRPAPGYPSQPDHTEKLTMWRLADIEQSTGIRL
-
-
-
-
Indications d'application
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Commentaires
-
MTR Blocking Peptide, (ABIN938943), is also available for use as a blocking control in assays to test for specificity of this MTR antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of MTR antibody in PBS
-
Concentration
- Lot specific
-
Buffer
- PBS
-
Conseil sur la manipulation
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- MTR (5-Methyltetrahydrofolate-Homocysteine Methyltransferase (MTR))
-
Autre désignation
- MTR
-
Sujet
- MTR is the enzyme 5-methyltetrahydrofolate-homocysteine methyltransferase. This enzyme, also known as cobalamin-dependent methionine synthase, catalyzes the final step in methionine biosynthesis. Mutations in MTR have been identified as the underlying cause of methylcobalamin deficiency complementation group G.
-
Poids moléculaire
- 140 kDa (MW of target protein)
-
Pathways
- Methionine Biosynthetic Process
Antigène
-